Sunitinib: from rational design to clinical efficacy.
Chow, Laura Q M
Sunitinib: from rational design to clinical efficacy. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar 2007 - 884-96 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1527-7755
10.1200/JCO.2006.06.3602 doi
Angiogenesis Inhibitors--therapeutic use
Animals
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--drug therapy
Clinical Trials as Topic
Drug Design
Gastrointestinal Stromal Tumors--drug therapy
Humans
Indoles--adverse effects
Kidney Neoplasms--drug therapy
Leukemia, Myeloid, Acute--drug therapy
Neoplasms--drug therapy
Protein Kinase Inhibitors--therapeutic use
Pyrroles--adverse effects
Sunitinib
Sunitinib: from rational design to clinical efficacy. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar 2007 - 884-96 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1527-7755
10.1200/JCO.2006.06.3602 doi
Angiogenesis Inhibitors--therapeutic use
Animals
Antineoplastic Agents--therapeutic use
Carcinoma, Renal Cell--drug therapy
Clinical Trials as Topic
Drug Design
Gastrointestinal Stromal Tumors--drug therapy
Humans
Indoles--adverse effects
Kidney Neoplasms--drug therapy
Leukemia, Myeloid, Acute--drug therapy
Neoplasms--drug therapy
Protein Kinase Inhibitors--therapeutic use
Pyrroles--adverse effects
Sunitinib